Abstract
Long-term Safety and Efficacy in Patients with DMD 4 Years Post-Treatment with Delandistrogene Moxeparvovec (SRP-9001) in a Phase 1/2a Study (P3-8.006)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have